Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV‐1 replication期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV‐1 replication

Authors:	A Borghetti G Baldin F Lombardi A Ciccullo A Capetti S Rusconi G Sterrantino A Latini MV Cossu R Gagliardini A De Luca S Di Giambenedetto

Affiliation:	1. Institute of Clinical Infectious Disease, Catholic University of the Sacred Heart, Rome, Italy;2. Division of Infectious Diseases, Department of Infectious Diseases, Luigi Sacco University Hospital, Milan, Italy;3. Infectious Diseases Unit, DIBIC Luigi Sacco, University of Milan, Milan, Italy;4. Division of Tropical and Infectious Diseases, ‘Careggi’ Hospital, Florence, Italy;5. Infectious Dermatology and Allergology Unit, IFO S. Gallicano Institute (IRCCS), Rome, Italy;6. University Division of Infectious Diseases, Siena University Hospital, Siena, Italy

Abstract:

Keywords:	antiretroviral therapy dolutegravir dual therapy lamivudine switch strategy